A Phase 2, Open-Label, Randomized, Master Protocol Study to Evaluate Safety and Efficacy of Multiple Treatment Combinations with ABBV-400 in Subjects with Metastatic Colorectal Cancer (M24-533 (AndroMETa-CRC-533))

Principal Investigator

Dr Victoria Woodcock

Contact us

Email: latephaseoncology@ouh.nhs.uk

IRAS number

1011725